Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Very interesting last 4 weeks on the Short Report.
How can so many trades on some of theses days involve buying and selling of so many short shares?
If true, I have not seen this type of action.
http://otcshortreport.com/?index=NWBO&action=view
I meant in regards to: "is preparing for production of DCVax-L products there" and "The Company and Advent are in the process of developing contract arrangements for manufacturing and related services for the U.K. and Europe." that this was the status 7 weeks ago.
Remember: this 10Q is dated Sept. 30th. (Over 7 weeks ago)
A lot has happened since. (Manufacturing & Finances)
Will we make .30 - go NWBO
The news of the day - thanks ccie1024
I wonder what time this was today or yesterday. Maybe it had something to do with the price action.
Sojourner55: so far, what are you thinking in regards to your your comment yesterday?
"If tomorrow opens and closes like this we get another financing"
Also from the NWBO February PR:
This process started before reaching the final OS event #233.
It's been awhile since there's been any real movement.
Churning and more churning, but nothing really happening with price.
Manipulation to short and buy back, making a few cents?
4/29/2017______ 0.18000
5/6/2017_______ 0.17936
5/13/2017______ 0.15950
5/20/2017______ 0.15500
5/27/2017______ 0.17500
6/3/2017_______ 0.18300
6/10/2017______ 0.15800
6/17/2017______ 0.14500
6/24/2017______ 0.17800
7/1/2017_______ 0.16400
7/8/2017_______ 0.18000
7/15/2017______ 0.29000
7/22/2017______ 0.24950
7/29/2017______ 0.24000
8/5/2017_______ 0.23710
8/12/2017______ 0.18900
8/19/2017______ 0.20000
8/26/2017______ 0.17500
9/2/2017_______ 0.16800
9/9/2017_______ 0.18000
9/16/2017______ 0.18750
9/23/2017______ 0.17200
9/30/2017______ 0.17830
10/7/2017______ 0.16830
10/14/2017_____ 0.16750
10/21/2017_____ 0.17000
10/28/2017_____ 0.16535
11/4/2017______ 0.16800
Short Interest did increase the 2nd half of October
10/31/2017
NORTHWEST BIOTHERAPEUTICS INC
4,073,599 as of 10/31/2017
3,537,013 as of 10/13/2017
+ 536,586 INCREASE
http://otce.finra.org/ESI
While shares are being churned, there's likely some shorting going on to help keep the price down for various reasons.
Shortable Stocks for NWBO down to 850,000 this morning
Was at 6M+ a few weeks ago.
https://www.interactivebrokers.com/en/index.php?key=NWBO&cntry=usa&tag=United+States&ib_entity=llc&ln=&asset=&f=4587&conf=am&amref=1
Shortable Stock available only 1,500,000 now
https://www.interactivebrokers.com/en/index.php?key=NWBO&cntry=usa&tag=United+States&ib_entity=llc&ln=&asset=&f=4587&conf=am&amref=1
Yes, correct. This is a small part of a standard 5-year Business Plan for the company growth.
We were at 6,300,000 available shares to short 2 weeks ago.
We are presently at 2,600,000 legal shares.
https://www.interactivebrokers.com/en/index.php?key=NWBO&cntry=usa&tag=United+States&ib_entity=llc&ln=&asset=&f=4587&conf=am&amref=1
There's been a decrease I the NWBO shortable shares available. Now down to 3,600,000
https://www.interactivebrokers.com/en/index.php?key=NWBO&cntry=usa&tag=United+States&ib_entity=llc&ln=&asset=&f=4587&conf=am&amref=1
Yes, you are likely correct.
There are now at least 5,800,000 shares available for legal shorting. Whereas, 2 weeks ago, there was not. In all likelihood, many of these shares provided were used for covering sold shares.
https://www.interactivebrokers.com/en/index.php?key=NWBO&cntry=usa&tag=United+States&ib_entity=llc&ln=&asset=&f=4587&conf=am&amref=1
High NWBO Buy volume so far today.
http://www.advfn.com/stock-market/USOTC/NWBO/trades
How many shares will NITE-CDEL-ETRF-CSTI sell today?
http://www.otcmarkets.com/stock/NWBO/quote
Are Citadel Securities (CDEL) and VIRTU Americas LLC (NITE) formerly Knight Capital or Trading Group, both part of the same corporation?
Doesn't FDA approval require manufacturing capabilities in place, along with a successful product?
Thanks. An excellent technical analysis and brilliant thoughts on what has happened. I hadn't really thought about "shenanigans", so that clearly explains and now I can sleep well tonight.
Thanks again and good night!
The way I see it. The price was $.18 at the end of April and has not been higher, so how could the shares have been sold in the $.30's?
Very nice find Flipper!!! - thanks for the update
Yes, NWBIO has reached a milestone.
I believe they are at a point in which they will no longer need outside financing to reach trial endpoints.
Thanks, Etienne1. Yes I've been around for quite awhile. Not as long as some, but probably more than a lot. This is my only stock and has been for some time. I have added shares as the years have gone by and as a result have averaged down since 1st purchasing in the $3 range.
I can say one thing, I've always had a lot of patience and this adventure has been a true test of such.
Hopefully, we will soon see results and many of us will have a remarkable story to tell to our grandkids! LOL.
Bio, I agree with you on most of what you're saying, but they may find it difficult getting their shares cheaply once the good news finally hits. I know I'm not selling cheaply. I guess it may depend upon what they would consider cheap. Is $30 cheap?
"UCLA’s Linda Liau, a top neurosurgeon who developed the first cellular vaccine for brain cancer. At 19, she had already graduated from Brown University, then sold houses on commission to pay her way through Stanford Medical School. As you can guess, she was debt-free upon graduation."
http://poetsandquantsforexecs.com/2016/06/13/best-brightest-embas-class-2016/2/
I had never heard that!
NWBO + DCVax + Cofer Black = Protection
From your Wikipedia link: https://en.wikipedia.org/wiki/Cofer_Black
Ex: not so. I believe your wrong on this one point.
WSJ: Biotech Stocks Under Scanner -- Rexahn Pharma, Northwest Biotherapeutics, Celldex Therapeutics, and Vertex Pharma
https://www.wsj.com/articles/PR-CO-20170331-908410
---if you have a subscription. I do not.
Thanks, Sharpie. Great follow-up on Jamil in the news.
It would be nice if this news had spread across media outlets.
Thanks for clarifying. Makes sense now!
Antihama, with the multi-month process starting in early February, and the company's expectation to reach 233 OS events in several months from early February, why are you thinking December?
Short Interest:
03/15/2017 - 7,540,863
02/28/2017 - 6,060,317
02/15/2017 - 4,240,238
01/31/2017 - 2,108,525
http://otce.finra.org/ESI
Today's shares being bought primarily at the offer:
http://www.advfn.com/stock-market/USOTC/NWBO/trades